Geode Capital Management, LLC Relay Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.39 Trillion
Q2 2025

A detailed history of Geode Capital Management, LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 3,229,666 shares of RLAY stock, worth $22.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,229,666

Previous 3,070,118 5.2%

Holding current value

$22.7 Million

Previous $8.04 Million 38.93%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$2.0 - $3.49 $319,096 - $556,822	159,548 Added 5.2%	3,229,666 $11.2 Million
Q1 2025 May 13, 2025	BUY	$2.62 - $4.92 $104,697 - $196,608	39,961 Added 1.32%	3,070,118 $8.04 Million
Q4 2024 Feb 12, 2025	BUY	$4.12 - $6.8 $1.23 Million - $2.03 Million	297,887 Added 10.9%	3,030,157 $12.5 Million
Q3 2024 Nov 12, 2024	BUY	$6.23 - $9.51 $2.29 Million - $3.49 Million	367,473 Added 15.54%	2,732,270 $19.3 Million
Q2 2024 Aug 09, 2024	BUY	$5.9 - $8.02 $873,223 - $1.19 Million	148,004 Added 6.68%	2,364,797 $15.4 Million
Q1 2024 May 13, 2024	BUY	$7.5 - $12.07 $1.01 Million - $1.63 Million	135,283 Added 6.5%	2,216,793 $18.4 Million
Q4 2023 Feb 13, 2024	BUY	$6.01 - $11.48 $664,237 - $1.27 Million	110,522 Added 5.61%	2,081,510 $22.9 Million
Q3 2023 Nov 13, 2023	BUY	$8.24 - $12.97 $739,358 - $1.16 Million	89,728 Added 4.77%	1,970,988 $16.6 Million
Q2 2023 Aug 11, 2023	BUY	$9.99 - $18.27 $1.27 Million - $2.32 Million	126,730 Added 7.22%	1,881,260 $23.6 Million
Q1 2023 May 15, 2023	BUY	$15.0 - $22.76 $906,135 - $1.37 Million	60,409 Added 3.57%	1,754,530 $28.9 Million
Q4 2022 Feb 13, 2023	BUY	$14.16 - $24.02 $2.03 Million - $3.44 Million	143,146 Added 9.23%	1,694,121 $25.3 Million
Q3 2022 Nov 14, 2022	BUY	$18.07 - $31.37 $2.25 Million - $3.9 Million	124,251 Added 8.71%	1,550,975 $34.7 Million
Q2 2022 Aug 12, 2022	BUY	$13.31 - $34.88 $988,227 - $2.59 Million	74,247 Added 5.49%	1,426,724 $23.9 Million
Q1 2022 May 13, 2022	BUY	$20.26 - $32.36 $961,559 - $1.54 Million	47,461 Added 3.64%	1,352,477 $40.5 Million
Q4 2021 Feb 11, 2022	BUY	$26.0 - $37.03 $6.23 Million - $8.88 Million	239,756 Added 22.51%	1,305,016 $40.1 Million
Q3 2021 Nov 12, 2021	BUY	$29.75 - $37.99 $10.6 Million - $13.6 Million	357,365 Added 50.48%	1,065,260 $33.6 Million
Q2 2021 Aug 13, 2021	BUY	$27.5 - $38.19 $2.86 Million - $3.97 Million	103,962 Added 17.21%	707,895 $25.9 Million
Q1 2021 May 12, 2021	BUY	$32.52 - $61.53 $5.14 Million - $9.72 Million	157,909 Added 35.4%	603,933 $20.9 Million
Q4 2020 Feb 12, 2021	BUY	$35.51 - $54.03 $321,081 - $488,539	9,042 Added 2.07%	446,024 $18.5 Million
Q3 2020 Nov 13, 2020	BUY	$32.81 - $45.1 $14.3 Million - $19.7 Million	436,982 New	436,982 $18.6 Million

Others Institutions Holding RLAY

# of Institutions

213

Shares Held

173M

Call Options Held

Put Options Held

36.1K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $846M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Relay Therapeutics, Inc. Transaction History